AZZAD ASSET MANAGEMENT INC /ADV

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1121914 FALLS CHURCH, VA

Position in ALNY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,393,768

-$125,256 QoQ

Shares Held

4,630

+0.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#365

of 784 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

AZZAD ASSET MANAGEMENT INC /ADV holds $5,807,017 across 7 Biotechnology names. ALNY ranks #1 (24.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc. This page	4,630	$1,393,768
2	INCY	Incyte Corp	9,067	$1,027,835
3	TECH	BIO-TECHNE Corp	14,008	$989,665
4	HALO	Halozyme Therapeutics, Inc.	12,424	$972,426
5	REGN	Regeneron Pharmaceuticals, Inc.	984	$613,563
6	EXEL	Exelixis, Inc.	7,911	$430,437
7	IONS	Ionis Pharmaceuticals Inc	4,784	$379,323

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,393,768	4,630	+0.8%	Shares	Sole	2026-07-29
2026-03-31	$1,519,024	4,591	0.0%	Shares	Sole	2026-04-30
2025-12-31	$1,825,611	4,591	-0.6%	Shares	Sole	2026-01-21
2025-09-30	$2,106,720	4,620	+74.3%	Shares	Sole	2025-11-05
2025-06-30	$864,464	2,651	-2.7%	Shares	Sole	2025-07-31
2023-06-30	$517,586	2,725	+0.4%	Shares	Sole	2024-04-01
2023-03-31	$543,668	2,714	+0.7%	Shares	Sole	2024-04-01
2022-12-31	$640,466	2,695	+0.9%	Shares	Sole	2024-04-01
2022-09-30	$534,627	2,671	+0.2%	Shares	Sole	2024-04-01
2022-06-30	$388,836	2,666	+2.4%	Shares	Sole	2024-04-01
2022-03-31	$425,207	2,604	-3.1%	Shares	Sole	2024-04-01
2021-12-31	$455,661	2,687	—	Shares	Sole	2024-04-01
No filing history on record for this holder in this stock.